Detalhe da pesquisa
1.
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 95(5): 410-418, 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37940409
2.
Odour discrimination and identification as a biomarker of long-term disability worsening in multiple sclerosis.
Mult Scler
; 30(1): 55-62, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37850472
3.
Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement.
Mult Scler
; 29(2): 182-195, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36527368
4.
Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis.
Mult Scler
; 29(2): 169-181, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36453167
5.
Immunization status in patients with multiple sclerosis: A cross-sectional, monocenter study in Austria.
Eur J Neurol
; 30(5): 1400-1408, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36786310
6.
Sexual dysfunction in female and male people with multiple sclerosis: disability, depression and hormonal status matter.
Eur J Neurol
; 30(4): 991-1000, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36694294
7.
Lower initial red blood cell count in cerebrospinal fluid predicts good functional outcome in patients with spontaneous subarachnoid haemorrhage.
Eur J Neurol
; 30(8): 2315-2323, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37161833
8.
Retinal layer thickness predicts disability accumulation in early relapsing multiple sclerosis.
Eur J Neurol
; 30(4): 1025-1034, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36719184
9.
Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients.
J Neuroinflammation
; 19(1): 19, 2022 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35057809
10.
Olfactory threshold predicts treatment response in relapsing multiple sclerosis.
Mult Scler
; 28(10): 1541-1552, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35282741
11.
Retinal layer thinning as a biomarker of long-term disability progression in multiple sclerosis.
Mult Scler
; 28(12): 1871-1880, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35652366
12.
Long-term outcome after COVID-19 infection in multiple sclerosis: a nation-wide multicenter matched-control study.
Eur J Neurol
; 2022 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35751475
13.
Comparing humoral immune response to SARS-CoV2 vaccines in people with multiple sclerosis and healthy controls: An Austrian prospective multicenter cohort study.
Eur J Neurol
; 29(5): 1538-1544, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35102646
14.
Impact of vaccination on COVID-19 outcome in multiple sclerosis.
Eur J Neurol
; 2022 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35791496
15.
Sudomotor dysfunction in people with neuromyelitis optica spectrum disorders.
Eur J Neurol
; 29(9): 2772-2780, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35598288
16.
Anti-NMDA receptor encephalitis and MOG-associated demyelination - a case report with long-term follow-up and a systematic review.
BMC Neurol
; 22(1): 434, 2022 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36384491
17.
Caspr2 antibodies in herpes simplex encephalitis: an extension of the spectrum of virus induced autoimmunity? - A case report.
BMC Neurol
; 22(1): 131, 2022 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35382753
18.
Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis-from diagnosis to prediction of disease activity.
Wien Med Wochenschr
; 172(15-16): 337-345, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35133530
19.
Natalizumab treatment during pregnancy in multiple sclerosis-clinical and bioethical aspects of an ongoing debate.
Wien Med Wochenschr
; 172(15-16): 373-378, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35142953
20.
Macular ganglion cell-inner plexiform layer thinning as a biomarker of disability progression in relapsing multiple sclerosis.
Mult Scler
; 27(5): 684-694, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32613912